V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 240008622 | 240005264 | 1.83 | 66.4 | null | 2017-05-26 | 2017-06-03 | Bortezomib (weekly) | N | N | 240018602 | G-CVP |
| 240008623 | 240005264 | 1.65 | 57 | Palliative (P) | null | 2018-10-28 | Paclitaxel+Trastuzumab wkly Maint | null | N | 240018602 | FCR |
| 240008624 | 240005265 | 1.65 | 62.4 | Curative (C) | 2016-06-12 | 2016-06-15 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN | 01 | N | 240018644 | GEMCITABINE |
| 240008625 | 240005266 | 1.61 | 58.1 | Curative (C) | 2016-07-05 | 2016-07-05 | Escalated BEACOPP | N | N | 240018669 | IDARUBICIN + MERCAPTOPURINE + METHOTREXATE + VINCRISTINE |
| 240008626 | 240005266 | 1.6 | null | null | null | 2017-06-17 | DA-EPOCH-R | N | N | 240018669 | RCEOP |
| 240008627 | 240005267 | 1.64 | 72 | Curative (C) | 2018-10-09 | 2018-10-09 | Vinblastine | N | N | 240018715 | DOCETAXEL |
| 240008628 | 240005267 | 1.79 | 58 | Palliative (P) | 2014-12-27 | 2015-01-02 | Cisplatin + Etoposide (3 day) | 02 | N | 240018715 | CYTARABINE |
| 240008629 | 240013634 | 1.69 | 53 | Palliative (P) | 2013-11-06 | 2014-04-09 | BEVACIZUMAB + CISPLATIN + PACLITAXEL | N | N | 240018751 | NHL 2003 |
| 240008630 | 240005268 | null | 80 | null | 2013-03-29 | 2013-03-31 | DA-EPOCH-R | N | null | 240018886 | FCR |
| 240008631 | 240005269 | 1.56 | 58.4 | Curative (C) | 2013-05-06 | 2013-05-07 | FCR IV - Cycle 2 onwards | 2 | N | 240018935 | CHOEP |
| 240008632 | 240005269 | 1.65 | 68 | Palliative (P) | 2013-06-08 | 2013-07-08 | Capecitabine | 02 | N | 240018935 | CISPLATIN + FLUOROURACIL |
| 240008633 | 240005269 | 1.7 | 61.8 | Not known (9) | 2017-09-21 | 2017-09-22 | ABVD | N | N | 240018935 | ABVD |
| 240008634 | 240005270 | 1.58 | 66.7 | Disease modification (D) | 2016-02-18 | 2016-02-22 | ABVD | N | N | 240019010 | METHOTREXATE |
| 240008635 | 240005271 | 1.81 | null | null | null | 2014-04-13 | CYTARABINE + Vosaroxin | null | null | 240019016 | OXALIPLATIN |
| 240008636 | 240010912 | 1.69 | 58.4 | Disease modification (D) | 2017-03-28 | 2017-04-02 | BEVACIZUMAB + CISPLATIN + PACLITAXEL | 02 | null | 240019105 | CYTARABINE |
| 240008637 | 240013636 | 1.71 | 44.9 | null | null | 2016-08-29 | LENALIDOMIDE | N | null | 240019130 | EC |
| 240008638 | 240005272 | 1.8 | 84 | Curative (C) | 2014-11-12 | 2014-11-12 | Triple Intrathecal | Y | N | 240019157 | FCR |
| 240008639 | 240005273 | null | 0 | Adjuvant (A) | 2018-10-07 | 2018-10-13 | Methotrexate intrathecal | 02 | N | 240019224 | CVD R |
| 240008640 | 240005274 | 1.8 | 80.8 | Disease modification (D) | 2017-01-26 | 2017-02-01 | ABVD | 02 | N | 240019249 | FCR |
| 240008641 | 240005274 | 1.8 | 82 | Palliative (P) | null | 2014-10-20 | Docetaxel 75mg/m2 (21 day) | N | N | 240019249 | FLUDARABINE |
| 240008642 | 240005275 | 1.59 | 51 | Curative (C) | 2013-11-11 | 2013-11-25 | DOCETAXEL + GEMCITABINE | N | N | 240019317 | CAPECITABINE + OXALIPLATIN |
| 240008643 | 240005275 | null | null | null | 2017-06-29 | 2017-07-13 | BEAM | N | N | 240019317 | CYTARABINE |
| 240008644 | 240005275 | 1.57 | 50 | Palliative (P) | 2015-12-07 | 2015-12-14 | FLAG + Idarubicin | N | N | 240019317 | LENALIDOMIDE |
| 240008645 | 240005276 | null | 54 | Not known (9) | 2016-09-06 | 2016-09-11 | ESHAP R | N | N | 240019414 | CISPLATIN + VINORELBINE |
| 240008646 | 240005277 | 1.55 | 62.8 | Adjuvant (A) | 2016-06-29 | 2016-06-29 | RCEOP | N | N | 240019431 | FCR |
| 240008647 | 240005278 | null | 86 | Curative (C) | 2017-04-14 | 2017-04-14 | CAPECITABINE + RT | N | N | 240019454 | CYCLOPHOSPHAMIDE + RITUXIMAB |
| 240008648 | 240005279 | 1.71 | null | Palliative (P) | 2018-09-25 | 2018-10-03 | ALEMTUZUMAB + BUSULFAN + FLUDARABINE | 02 | N | 240019478 | VINBLASTINE |
| 240008649 | 240005280 | 1.65 | 77.6 | Palliative (P) | 2015-05-13 | 2015-05-25 | Fludarabine + Melphalan RIC Allo | 2 | N | 240019486 | CTD |
| 240008650 | 240005281 | 1.55 | 56.5 | Curative (C) | 2016-11-08 | 2016-11-16 | Bevacizumab+Carbo+Gemcitabine | 02 | N | 240019507 | R-EPOCH |
| 240008651 | 240005282 | 1.64 | 87.5 | Disease modification (D) | 2017-07-10 | 2017-07-23 | CHOP R + METHOTREXATE | 2 | N | 240019517 | POMALIDOMIDE |
| 240008652 | 240010915 | 0 | 84 | Disease modification (D) | 2016-06-17 | 2016-06-29 | PMitCEBO-R | 2 | N | 240019520 | ATG + BUSULFAN + FLUDARABINE |
| 240008653 | 240005283 | null | 70.1 | Palliative (P) | null | 2017-05-25 | Dacarbazine | N | null | 240019568 | VEDEX |
| 240008654 | 240005283 | 1.52 | 55.6 | Palliative (P) | 2018-04-23 | 2018-04-24 | CYCLOPHOSPHAMIDE + THALIDOMIDE | 2 | N | 240019568 | R CODOX M |
| 240008655 | 240005283 | 1.53 | 62.6 | Adjuvant (A) | 2017-09-14 | 2017-09-14 | FLAG + Idarubicin | N | N | 240019568 | CISPLATIN + VINORELBINE |
| 240008656 | 240005283 | 1.76 | 64.7 | Disease modification (D) | 2017-03-17 | 2017-03-24 | Imatinib 400mg | null | N | 240019568 | DOXORUBICIN |
| 240008657 | 240005283 | 1.64 | 80 | Palliative (P) | null | 2016-09-18 | CHOP-R + CYTARABINE HIGH DOSE | N | null | 240019568 | OEPA |
| 240008658 | 240005284 | 1.54 | 51.2 | Palliative (P) | null | 2016-07-04 | Cisplatin + Etoposide po&iv 3 day | null | null | 240019635 | PACLITAXEL |
| 240008659 | 240005284 | null | null | Neo-adjuvant (N) | 2017-05-11 | 2017-05-11 | Cyclophosphamide Fludarabine (Oral) | null | N | 240019635 | CYCLOPHOSPHAMIDE + RITUXIMAB + VINCRISTINE |
| 240008660 | 240005285 | 1.54 | 55 | Palliative (P) | null | 2018-01-10 | Cisplatin + Etoposide + RT | N | N | 240019671 | FLUDARABINE |
| 240008661 | 240005285 | 1.88 | 60.6 | Palliative (P) | 2013-09-04 | 2013-09-05 | Cytarabine HD + Rituximab | Y | N | 240019671 | INCA TRIAL |
| 240008662 | 240005286 | 1.73 | 84 | Curative (C) | 2013-04-26 | 2013-05-17 | Sunitinib | N | N | 240019720 | CYCLOPHOSPHAMIDE + RITUXIMAB + VINCRISTINE |
| 240008663 | 240005287 | 1.59 | 73.1 | Palliative (P) | null | 2014-01-02 | Erlotinib | N | N | 240019744 | ABVD |
| 240008664 | 240005288 | 1.76 | null | null | 2015-07-15 | 2015-07-31 | Cyclophosphamide Weekly PO | null | N | 240019785 | ABIRATERONE |
| 240008665 | 240010919 | null | 58 | null | 2015-08-14 | 2015-08-15 | Capecitabine + Oxaliplatin 21day | 2 | N | 240019807 | FLAG |
| 240008666 | 240013639 | 1.54 | null | null | null | 2013-02-01 | FLAG | Y | null | 240019851 | mEOC TRIAL |
| 240008667 | 240005289 | 1.71 | 82.3 | Curative (C) | 2013-04-22 | 2013-04-22 | Methotrexate intrathecal | N | N | 240019889 | CVD R |
| 240008668 | 240010920 | 1.7 | 72.6 | Curative (C) | null | 2013-05-15 | FLAG + Idarubicin | N | N | 240019900 | CISPLATIN + TOPOTECAN |
| 240008669 | 240010920 | 1.65 | 68.6 | Curative (C) | 2017-12-27 | 2018-01-10 | DA-EPOCH-R | N | N | 240019900 | FCR |
| 240008670 | 240010920 | 1.54 | 75.3 | Curative (C) | 2018-05-01 | 2018-05-02 | Cytarabine Low Dose | 2 | Y | 240019900 | CISPLATIN + FLUOROURACIL + RT |
| 240008671 | 240005290 | 0 | 67.2 | Curative (C) | 2019-07-17 | 2019-07-17 | Cisplatin + Topotecan | 02 | N | 240019968 | CISPLATIN + TOPOTECAN |